Abstract
A variety of oxidative and conjugative enzymes are involved in the metabolism of compounds including drugs, which can be converted into toxic metabolites by Phase I drug-metabolizing enzymes (DMEs), such as the cytochromes P450 (CYP450s), and/or detoxified by Phase II DMEs, such as UDP-glucuronosyltransferases (UGTs), sulfotransferases (SULTs), and glutathione S-transferases (GSTs). Traditionally, primary hepatocytes containing a complete set of DMEs have been widely used as a gold standard to assess metabolism-induced compound toxicity. However, primary hepatocytes are expensive, have high donor variability in expression levels of DMEs, and rapidly lose liver-specific functions when the cells are maintained under standard in vitro cell culture conditions over time. To address this issue and rapidly profile metabolism-induced drug toxicity, we have developed a 384-pillar plate, which is complementary to conventional 384-well plates. In this chapter, we provide step-by-step procedures for three-dimensional (3D) cell printing on the 384-pillar plate coupled with DMEs and compounds in the 384-well plate for high-throughput assessment of metabolism-induced toxicity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
May JE, Xu J, Morse HR et al (2009) Toxicity testing: the search for an in vitro alternative to animal testing. Br J Biomed Sci 66:160–165
Paul SM, Mytelka DS, Dunwiddie CT et al (2010) How to improve R&D productivity: the pharmaceutical industry’s grand challenge. Nat Rev Drug Discov 9:203–214
Lee M-Y, Clark DS, Dordick JS (2006) Human P450 microarrays for in vitro toxicity analysis: toward complete automation of human toxicology screening. J Assoc Lab Autom 11:374–380
EPA. Transform Tox Testing Challenge. https://www.challenge.gov/assets/document-library/Transform-Tox-Testing-Challenge-Stage-2-Update1.pdf
Lee M-Y, Park CB, Dordick JS et al (2005) Metabolizing enzyme toxicology assay chip (MetaChip) for high-throughput microscale toxicity analyses. Proc Natl Acad Sci 102:983–987
Lee M-Y, Kumar RA, Sukumaran SM et al (2008) Three-dimensional cellular microarray for high-throughput toxicology assays. Proc Natl Acad Sci 105:59–63
Kwon SJ, Lee DW, Shah DA et al (2014) High-throughput and combinatorial gene expression on a chip for metabolism-induced toxicology screening. Nat Commun 5:1–12
Yu KN, Kang SY, Hong S et al (2018) High-throughput metabolism-induced toxicity assays demonstrated on a 384-pillar plate. Arch Toxicol 92:2501–2516
Acknowledgments
This work was partially supported by the US Environmental Protection Agency (US EPA Transform Tox Testing Challenge), Medical & Bio Device (MBD) Korea, the Cleveland State University (Faculty Innovation Fund), and the National Institutes of Health (NIEHS R01ES025779).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Kang, SY., Yu, KN., Joshi, P., Lee, MY. (2020). High-Throughput Assessment of Metabolism-Induced Toxicity of Compounds on a 384-Pillar Plate. In: Labrou, N. (eds) Targeting Enzymes for Pharmaceutical Development. Methods in Molecular Biology, vol 2089. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0163-1_13
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0163-1_13
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0162-4
Online ISBN: 978-1-0716-0163-1
eBook Packages: Springer Protocols